First, a comprehensive search was conducted across the Web of Science, Scopus, PubMed, Cochrane Central Register, Embase, and PsycINFO databases to identify randomized controlled trials (RCTs), preclinical studies, and clinical trials with control groups
Hepatic histopathology (Fig.4-A, B) showed that both semaglutide and tirzepatide significantly reduced the non-alcoholic fatty liver disease activity score (NAS) by decreasing steatosis and cell ballooning, compared to the non-restricted diet model group
ISBN 978-0323400046
HDAC6 is a positive regulator of HSP90 and increases HSP90 levels to inhibit mutant p53 degradation
A long-acting amylin analog for the treatment of obesity
BPC-157 Mechanisms of Action Promotion of Accelerated Healing: BPC-157 has been shown to accelerate the healing process by stimulating the production of growth factors and promoting the formation of new blood vessels (angiogenesis) at the site of injury or damage [1]